Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
International Business Machines Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $221.3B | |
|---|---|---|
| Revenue (ttm) | 69.9B | |
| Net income (ttm) | 11.2B | |
| EPS (ttm) | $11.7 | |
| Shares out | 945.1M | |
| P/E (trailing) | 21.6x | |
| P/E (forward) | 17.6x | |
| Dividend | $6.76 (2.67%) | |
| Volume | 2,696,553 | |
| Beta | 0.72 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $57.35B | $60.53B | $61.86B | $62.75B | $67.54B | +4.2% |
| Gross profit | $31.49B | $32.69B | $34.30B | $35.55B | $39.30B | +5.7% |
| Operating income | $7.02B | $2.37B | $7.51B | $7.51B | $12.26B | +15.0% |
| Net income | $5.74B | $1.64B | $7.50B | $6.02B | $10.59B | +16.5% |
| EPS (diluted) | $6.35 | $1.80 | $8.14 | $6.43 | $11.17 | +15.2% |
| EBITDA | $13.44B | $7.17B | $7.51B | $12.18B | $17.28B | +6.5% |
| R&D | $6.49B | $6.57B | $6.78B | $7.48B | $8.32B | +6.4% |
| SG&A | $18.75B | $18.61B | $19.00B | $19.69B | $20.12B | +1.8% |
Recent company headlines from major financial publishers.
This path requires modest sales growth and stable margins. Weaker cash generation or estimate delivery would disconfirm it.
Sustained estimate delivery and dated support beyond FY2027 would keep upside alive. Weaker estimates or cash generation would disconfirm it.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.2% | $271 | $294 | $325 | $368 | $435 |
| 6.2% | $231 | $244 | $261 | $283 | $312 |
| 7.2% | $204 | $212 | $224 | $235 | $251 |
| 8.2% | $184 | $190 | $197 | $205 | $215 |
| 9.2% | $169 | $173 | $178 | $183 | $190 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |